US2015320744A1PendingUtilityA1

Preparations and Methods for Ameliorating or Reducing Presbyopia

61
Assignee: HEK DEV LLCPriority: May 22, 2009Filed: Jul 17, 2015Published: Nov 12, 2015
Est. expiryMay 22, 2029(~2.8 yrs left)· nominal 20-yr term from priority
Inventors:Herbert E. Kaufman
A61K 31/27A61K 31/498A61K 9/0048A61K 31/325A61P 27/10A61P 27/02A61K 45/06
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This application relates to the use of one or more parasympathomimetic drugs in combination with one or more alpha agonists to create optically beneficial miosis to, for example, temporarily treat presbyopia. The invention provides a pharmaceutical preparation comprising a therapeutically effective amount of one or more parasympathomimetic drugs or cholinesterase inhibitors, or a pharmaceutically acceptable salt thereof, in combination with one or more alpha agonists or antagonists, or a pharmaceutically acceptable salt thereof. The invention further provides for a method for treating, ameliorating or reducing presbyopia of a patient having an eye, comprising administering to said eye a pharmaceutically effective amount of the ophthalmic preparation.

Claims

exact text as granted — not AI-modified
1 . A method for ameliorating or reducing presbyopia of a patient having an eye, comprising administering to said eye an ophthalmic preparation comprising a therapeutically effective amount of carbachol, or pharmaceutically acceptable salts thereof, and brimonidine, or pharmaceutically acceptable salts thereof. 
     
     
         2 . The method of  claim 1 , wherein carbachol is present in the preparation in an amount of 1.5-5%. 
     
     
         3 . The method of  claim 1 , wherein carbachol is present in the preparation in an amount of 2.25-3.5%. 
     
     
         4 . The method of  claim 1 , wherein brimonidine is present in the preparation in an amount of 0.05-0.3%. 
     
     
         5 . A method of producing ocular miosis in a subject which comprises administering to the subject an amount of an ophthalmic preparation comprising a therapeutically effective amount of carbachol, or pharmaceutically acceptable salts thereof, and brimonidine, or pharmaceutically acceptable salts thereof, effective to produce ocular miosis. 
     
     
         6 . The method of  claim 5 , wherein carbachol is present in the preparation in an amount of 1.5-5%. 
     
     
         7 . The method of  claim 5 , wherein carbachol is present in the preparation in an amount of 2.25-3.5%. 
     
     
         8 . The method of  claim 5 , wherein brimonidine is present in the preparation in an amount of 0.05-0.3%. 
     
     
         9 . A method for ameliorating or reducing presbyopia of a patient, comprising administering to one eye of the patient a therapeutically effective amount of an ophthalmic preparation comprising a therapeutically effective amount of carbachol, or pharmaceutically acceptable salts thereof, and brimonidine, or pharmaceutically acceptable salts thereof. 
     
     
         10 . The method of  claim 9 , wherein carbachol is present in the preparation in an amount of 1.5-5%. 
     
     
         11 . The method of  claim 9 , wherein carbachol is present in the preparation in an amount of 2.25-3.5%. 
     
     
         12 . The method of  claim 9 , wherein brimonidine is present in the preparation in an amount of 0.05-0.3%. 
     
     
         13 . A method of ameliorating, reducing or eliminating dimness of vision of a patient having an eye comprising administering to said eye a therapeutically effective amount of an ophthalmic preparation comprising a therapeutically effective amount of carbachol, or pharmaceutically acceptable salts thereof, and brimonidine, or pharmaceutically acceptable salts thereof. 
     
     
         14 . The method of  claim 13 , wherein carbachol is present in the preparation in an amount of 1.5-5%. 
     
     
         15 . The method of  claim 13 , wherein carbachol is present in the preparation in an amount of 2.25-3.5%. 
     
     
         16 . The method of  claim 13 , wherein brimonidine is present in the preparation in an amount of 0.05-0.3%. 
     
     
         17 . A method of improving focus and/or correcting refractive errors of a patient having an eye comprising administering to said eye a therapeutically effective amount of an ophthalmic preparation comprising a therapeutically effective amount of carbachol, or pharmaceutically acceptable salts thereof, and brimonidine, or pharmaceutically acceptable salts thereof. 
     
     
         18 . The method of  claim 17 , wherein carbachol is present in the preparation in an amount of 1.5-5%. 
     
     
         19 . The method of  claim 17 , wherein carbachol is present in the preparation in an amount of 2.25-3.5%. 
     
     
         20 . The method of  claim 17 , wherein brimonidine is present in the preparation in an amount of 0.05-0.3%. 
     
     
         21 . A method of treating presbyopia in a patient in need of treatment thereof comprising administering an effective amount of an ophthalmic preparation comprising a therapeutically effective amount of carbachol, or pharmaceutically acceptable salts thereof, and brimonidine to a single eye of a patient thereby leaving the other eye untreated. 
     
     
         22 . The method of  claim 21 , wherein carbachol is present in the preparation in an amount of 1.5-5%. 
     
     
         23 . The method of  claim 21 , wherein carbachol is present in the preparation in an amount of 2.25-3.5%. 
     
     
         24 . The method of  claim 21 , wherein brimonidine is present in the preparation in an amount of 0.05-0.3%.

Join the waitlist — get patent alerts

Track US2015320744A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.